BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10332590)

  • 1. The use of intravenous contrast in postoperative MR imaging of pituitary macroadenomas.
    Markus JB; Franchetto AA; Goh R
    Clin Imaging; 1999; 23(1):5-10. PubMed ID: 10332590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
    Steiner E; Math G; Knosp E; Mostbeck G; Kramer J; Herold CJ
    Clin Radiol; 1994 Aug; 49(8):524-30. PubMed ID: 7955862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images.
    Gao R; Isoda H; Tanaka T; Inagawa S; Takeda H; Takehara Y; Isogai S; Sakahara H
    Eur J Radiol; 2001 Sep; 39(3):139-46. PubMed ID: 11566239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
    Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
    Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of pituitary macroadenomas before and after transsphenoidal surgery.
    Hald JK; Nakstad PH; Kollevold T; Bakke SJ; Skalpe IO
    Acta Radiol; 1992 Sep; 33(5):396-9. PubMed ID: 1389642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
    Lundin P; Bergström K
    Acta Radiol; 1992 Jul; 33(4):323-32. PubMed ID: 1633042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
    Nakamura T; Schörner W; Bittner RC; Felix R
    Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of early postoperative MRI and diffusion-weighted imaging following trans-sphenoidal resection of non-functioning pituitary macroadenomas.
    Hassan HA; Bessar MA; Herzallah IR; Laury AM; Arnaout MM; Basha MAA
    Clin Radiol; 2018 Jun; 73(6):535-541. PubMed ID: 29329735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of MR tomography after transsphenoidal hypophyseal resection. A retrospective comparison between endocrinology, operation and MRT].
    Siewert B; Layer G; Müller MF; Kaiser WA; Hochstetter A; Solymosi L; Bootsveld K
    Rofo; 1994 Mar; 160(3):210-7. PubMed ID: 8136473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pituitary macroadenomas with multidetector-row CT (MDCT): comparison with MR imaging.
    Miki Y; Kanagaki M; Takahashi JA; Ishizu K; Nakagawa M; Yamamoto A; Fushimi Y; Okada T; Mikuni N; Kikuta K; Hashimoto N; Togashi K
    Neuroradiology; 2007 Apr; 49(4):327-33. PubMed ID: 17200863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of residual tumor tissue after transsphenoidal surgery of hormone-inactive pituitary macroadenomas: a prospective study.
    Kremer P; Forsting M; Hamer J; Sartor K
    Acta Neurochir Suppl; 1996; 65():27-30. PubMed ID: 8738489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of macroadenomas.
    Mohammad-Zadeh L
    Radiol Technol; 1995; 67(1):29-36; quiz 37-8. PubMed ID: 7491407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pituitary adenomas: value of MR imaging].
    Bonneville JF
    J Radiol; 2000 Sep; 81(9):939-42. PubMed ID: 10992090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of immediate postoperative MR imaging following endoscopic endonasal pituitary surgery.
    Stofko DL; Nickles T; Sun H; Dehdashti AR
    Acta Neurochir (Wien); 2014 Jan; 156(1):133-40; discussion 140. PubMed ID: 23982229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gd-DTPA in the MR diagnosis of pituitary adenomas].
    Steiner E; Wimberger D; Imhof H; Knosp E; Hajek P
    Rofo; 1989 Mar; 150(3):323-7. PubMed ID: 2538883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
    Sakamoto Y; Takahashi M; Korogi Y; Bussaka H; Ushio Y
    Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenomas: high-resolution MR imaging at 1.5 T.
    Kucharczyk W; Davis DO; Kelly WM; Sze G; Norman D; Newton TH
    Radiology; 1986 Dec; 161(3):761-5. PubMed ID: 3786729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The postoperative MR tomographic findings following the removal of a hypophyseal adenoma].
    Bader C; Goldmann A; Kunz U; Haeberle HJ; Friedrich JM
    Rofo; 1993 Nov; 159(5):476-80. PubMed ID: 8219144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients.
    Davis PC; Gokhale KA; Joseph GJ; Peterman SB; Adams DA; Tindall GT; Hudgins PA; Hoffman JC
    Radiology; 1991 Sep; 180(3):779-84. PubMed ID: 1871293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
    Wolfsberger S; Ba-Ssalamah A; Pinker K; Mlynárik V; Czech T; Knosp E; Trattnig S
    J Neurosurg; 2004 Feb; 100(2):278-86. PubMed ID: 15086236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.